European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk


Creative Commons License

Landmesser U., Chapman M. J., Farnier M., Gencer B., Gielen S., Hovingh G. K., ...More

EUROPEAN HEART JOURNAL, vol.38, no.29, pp.2245-2255, 2017 (SCI-Expanded, Scopus) identifier identifier identifier